| Dina Elizabeth Ford, MD | |
|
619 19th St S, Birmingham, AL 35249-1333 | |
| (205) 934-4696 | |
| Not Available |
| Full Name | Dina Elizabeth Ford |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 8 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083061360 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | T3279 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Medical Branch Faculty Group Practice | 3375456734 | 875 |
News Archive
An extended-release formulation of carbidopa–levodopa reduces the amount of off-time in patients with Parkinson's disease, show results from a phase III randomized trial.
For many, the months of July and August are a time for relaxation by the pool and vacation with the family, but this June, after several people in New York City were diagnosed with Legionnaire's disease in less than two weeks, an expert at New York Institute of Technology College of Osteopathic Medicine urges people to take caution.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.
Takara Bio Europe AB, formerly Cellartis AB, a wholly-owned subsidiary of Takara Bio Inc., announced today that it is launching an advanced cell culture medium for iPS cell culture. This chemically-defined culture medium is pre-clinical grade, free from human- and animal-derived components, and designed for efficient expansion of undifferentiated human iPS cells.
Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.
› Verified 2 days ago
| Entity Name | Utmb Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
An extended-release formulation of carbidopa–levodopa reduces the amount of off-time in patients with Parkinson's disease, show results from a phase III randomized trial.
For many, the months of July and August are a time for relaxation by the pool and vacation with the family, but this June, after several people in New York City were diagnosed with Legionnaire's disease in less than two weeks, an expert at New York Institute of Technology College of Osteopathic Medicine urges people to take caution.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.
Takara Bio Europe AB, formerly Cellartis AB, a wholly-owned subsidiary of Takara Bio Inc., announced today that it is launching an advanced cell culture medium for iPS cell culture. This chemically-defined culture medium is pre-clinical grade, free from human- and animal-derived components, and designed for efficient expansion of undifferentiated human iPS cells.
Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dina Elizabeth Ford, MD Po Box 650859 Dept 710, Dallas, TX 75265 Ph: (409) 266-7812 | Dina Elizabeth Ford, MD 619 19th St S, Birmingham, AL 35249-1333 Ph: (205) 934-4696 |
News Archive
An extended-release formulation of carbidopa–levodopa reduces the amount of off-time in patients with Parkinson's disease, show results from a phase III randomized trial.
For many, the months of July and August are a time for relaxation by the pool and vacation with the family, but this June, after several people in New York City were diagnosed with Legionnaire's disease in less than two weeks, an expert at New York Institute of Technology College of Osteopathic Medicine urges people to take caution.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.
Takara Bio Europe AB, formerly Cellartis AB, a wholly-owned subsidiary of Takara Bio Inc., announced today that it is launching an advanced cell culture medium for iPS cell culture. This chemically-defined culture medium is pre-clinical grade, free from human- and animal-derived components, and designed for efficient expansion of undifferentiated human iPS cells.
Just under 150 Perth women have contributed to major international research at the Telethon Institute for Child Health Research that has proved that the new Cervarix vaccine provides broader protection against cervical cancer.
› Verified 2 days ago
Riaz Mohammed Karukappadath, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Dr. Victor E. Mendoza, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5130 Cyrus Cir, Birmingham, AL 35242 Phone: 205-981-0414 | |
Joshua Edward Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Stacy Wade, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Bernis A Simmons, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 52 Medical Park Dr E, Suite 321, Birmingham, AL 35235 Phone: 205-838-3055 Fax: 205-838-3517 | |
George R. Wells Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Ave S, Birmingham, AL 35205 Phone: 205-930-7246 | |
Teddy W. Sartin, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1600 Carraway Blvd, Birmingham, AL 35234 Phone: 205-502-6817 Fax: 205-502-5152 |